Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial

Recruiting Phase 2 Interventional Study
Alcohol Use Disorder Alcohol Dependence Alcohol Abuse
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 65
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
80 (estimated)
Sponsor
University of Iowa · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study will collect data that measures the effects of a psychedelic intervention on patients struggling with alcohol use disorder (AUD). The study design will be a double blind, randomized, active-comparator trial with two study arms. Subjects randomized to Arm 1 (n=40) will receive individual psychotherapy sessions plus a 30 mg dose of psilocybin. Arm 2 subjects (n=40) will receive individual…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Weight between 50kg and 150kg * No known allergies to rescue medication * For people capable of becoming pregnant, not pregnant and using contraception * Not currently breastfeeding * Meets criteria for DSM-V moderate to severe AUD. * Have at least 4 heavy drinking days (5 or …
Contacts

Lindsay E Golden, BS

319-384-5243

lindsay-golden@uiowa.edu

CONTACT

Peggy C Nopoulos, MD

319-356-1144

peggy-nopoulos@uiowa.edu

CONTACT